All Stories

  1. To code or not to code chronic pulmonary aspergillosis associated malnutrition in PMSI database: that is the problem…

    Article • European Respiratory Journal, November 2021, European Respiratory Society (ERS)

    Dr Adrien Costantini

  2. Lung cancer is also a hereditary disease

    Article • European Respiratory Review, October 2021, European Respiratory Society (ERS)

    Dr Adrien Costantini

  3. Prevalence and prognosis of chronic pulmonary fungal infection due to Aspergillus spp.

    Article • European Respiratory Journal, January 2021, European Respiratory Society (ERS)

    Dr Adrien Costantini, Dr Thomas Maitre

  4. Landmark Studies of Targeted Therapies for Advanced Non-Small Cell Lung Cancer: A Guide for Pulmonologists

    Article • Current Respiratory Medicine Reviews, September 2020, Bentham Science Publishers

    Dr Adrien Costantini, CLEMENTINE BOSTANTZOGLOU

  5. ERS International Congress, Madrid, 2019: highlights from the Thoracic Oncology Assembly

    Article • ERJ Open Research, April 2020, European Respiratory Society (ERS)

    Dr Adrien Costantini

  6. Increased reporting of fatal pneumonitis associated with immune checkpoint inhibitors: a WHO pharmacovigilance database analysis

    Article • European Respiratory Journal, February 2020, European Respiratory Society (ERS)

    Dr Adrien Costantini

  7. Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer

    Article • European Respiratory Review, September 2019, European Respiratory Society (ERS)

    Dr Adrien Costantini

  8. Management of severe hemoptysis

    Article • Expert Review of Respiratory Medicine, September 2018, Taylor & Francis

    Dr Adrien Costantini

  9. Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

    Article • ERJ Open Research, April 2018, European Respiratory Society (ERS)

    Dr Adrien Costantini

  10. Pulmonary mucosa-associated lymphoid tissue lymphoma revisited

    Article • European Respiratory Journal, September 2016, European Respiratory Society (ERS)

    Dr Adrien Costantini

  11. Spotlight on crizotinib in the first-line treatment of ALK-positive advanced non-small-cell lung cancer: patients selection and perspectives

    Article • Lung Cancer Targets and Therapy, June 2016, Dove Medical Press

    Dr Adrien Costantini, vncent fallet

  12. Pulmonary mucosa-associated lymphoid tissue lymphoma revisited

    Article • European Respiratory Journal, January 2016, European Respiratory Society (ERS)

    Dr Adrien Costantini